Personalized cancer therapy—leveraging a knowledge base for clinical decision-making

av Dumbrava, Ecaterina Ileana, Meric-Bernstam, Funda
I publikationen Cold Spring Harb Mol Case Stud (2018)

Hypopigmented skin lesions on immunotherapy

av Dumbrava, Ecaterina Ileana, Ivan, Doina, Subbiah, Vivek
I publikationen JAMA Oncol (2018)

Complete Response to a Fibroblast Growth Factor Receptor Inhibitor in a Patient With Head and Neck Squamous Cell Carcinoma Harboring FGF Amplifications

av Ileana Dumbrava, Ecaterina, Alfattal, Rasha, Miller, Vincent A., Tsimberidou, Apostolia Maria
I publikationen JCO Precis Oncol (2018)

Autoimmune Granulomatous Inflammation of Lacrimal Glands and Axonal Neuritis Following Treatment With Ipilimumab and Radiation Therapy

av Ileana Dumbrava, Ecaterina, Smith, Veronica, Alfattal, Rasha, El-Naggar, Adel K., Penas-Prado, Marta, Tsimberidou, Apostolia M.
I publikationen J Immunother (2018)

Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss

av Owusu-Brackett, Nicci, Zhao, Ming, Akcakanat, Argun, Evans, Kurt W., Yuca, Erkan, Dumbrava, Ecaterina Ileana, Janku, Filip, Meric-Bernstam, Funda
I publikationen Oncotarget (2020)

TAK228 enhances antitumor activity of eribulin in triple negative breast cancer

av Owusu-Brackett, Nicci, Evans, Kurt W., Akcakanat, Argun, Yuca, Erkan, Tapia, Coya, Rizvi, Yasmeen Qamar, Dumbrava, Ecaterina Ileana, Janku, Filip, Meric-Bernstam, Funda
I publikationen Oncotarget (2019)

Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer

av Meric-Bernstam, Funda, Johnson, Amber M., Dumbrava, Ecaterina E. Ileana, Raghav, Kanwal P., Balaji, Kavitha, Bhatt, Michelle, Murthy, Rashmi K., Rodon, Jordi, Piha-Paul, Sarina A.
I publikationen Clin Cancer Res (2018)

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial

av Subbiah, Vivek, Dumbrava, Ecaterina Ileana, Jiang, Yunfang, Thein, Kyaw Z., Naing, Aung, Hong, David S., Fu, Siqing, Piha-Paul, Sarina A., Tsimberidou, Apostolia M., Janku, Filip, Meric-Bernstam, Funda, Kurzrock, Razelle, Falchook, Gerald
I publikationen Exp Hematol Oncol (2020)

Active Disclosure of Secondary Germline Findings to Deceased Research Participants’ Personal Representatives: Process and Outcomes

av Daniels, Molly, Wathoo, Chetna, Brusco, Lauren, Lu, Karen H., Shaw, Kenna, Dumbrava, Ecaterina E. Ileana, Arun, Banu, Strong, Louise, Litton, Jennifer K., Eterovic, Karina, Aytac, Ugur, Mendelsohn, John, Mills, Gordon B., Chen, Ken, Meric-Bernstam, Funda
I publikationen JCO Precis Oncol (2017)

First in class dual MDM2/MDMX inhibitor ALRN-6924 enhances antitumor efficacy of chemotherapy in TP53 wild-type hormone receptor-positive breast cancer models

av Pairawan, Seyed, Zhao, Ming, Yuca, Erkan, Annis, Allen, Evans, Kurt, Sutton, David, Carvajal, Luis, Ren, Jian-Guo, Santiago, Solimar, Guerlavais, Vincent, Akcakanat, Argun, Tapia, Coya, Yang, Fei, Bose, Priya Subash Chandra, Zheng, Xiaofeng, Dumbrava, Ecaterina Ileana, Aivado, Manuel, Meric-Bernstam, Funda
I publikationen Breast Cancer Res (2021)

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies

av Piha-Paul, Sarina A, Dumbrava, Ecaterina E, Nair, Binoj C, Xiong, Wendy, Xu, Li, Mostorino, Rosa, Subbiah, Vivek, Tannir, Nizar, Fu, Siqing, Naing, Aung, Janku, Filip, Karp, Daniel D, Patel, Shreyaskumar, Daw, Najat C, Hong, David, Meric-Bernstam, Funda, Zinner, Ralph
I publikationen Onco Targets Ther (2021)

PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE

av Kurnit, Katherine C., Ileana Dumbrava, Ecaterina E., Litzenburger, Beate, Khotskaya, Yekaterina B., Johnson, Amber M., Yap, Timothy A., Rodon, Jordi, Zeng, Jia, Shufean, Md Abu, Bailey, Ann M., Sánchez, Nora S., Holla, Vijaykumar, Mendelsohn, John, Shaw, Kenna Mills, Bernstam, Elmer, Mills, Gordon B., Meric-Bernstam, Funda
I publikationen Clin Cancer Res (2018)

Targeting ERBB2 (HER2) Amplification Identified by Next-Generation Sequencing in Patients With Advanced or Metastatic Solid Tumors Beyond Conventional Indications

av Dumbrava, Ecaterina E. Ileana, Balaji, Kavitha, Raghav, Kanwal, Hess, Kenneth, Javle, Milind, Blum-Murphy, Mariela, Ajani, Jaffer, Kopetz, Scott, Broaddus, Russell, Routbort, Mark, Demirhan, Mehmet, Zheng, Xiaofeng, Pant, Shubham, Tsimberidou, Apostolia M., Subbiah, Vivek, Hong, David S., Rodon, Jordi, Shaw, Kenna M., Piha-Paul, Sarina A., Meric-Bernstam, Funda
I publikationen JCO Precis Oncol (2019)

Expanded Analysis of Secondary Germline Findings From Matched Tumor/Normal Sequencing Identifies Additional Clinically Significant Mutations

av Ileana Dumbrava, Ecaterina, Brusco, Lauren, Daniels, Molly S., Wathoo, Chetna, Shaw, Kenna R., Lu, Karen H., Zheng, Xiaofeng, Strong, Louise C., Litton, Jennifer, Arun, Banu K., Eterovic, A. Karina, Routbort, Mark J., Patel, Keyur P., Qi, Yuan, Piha-Paul, Sarina A., Subbiah, Vivek, Hong, David S., Rodon, Jordi, Kopetz, Scott, Mendelsohn, John, Mills, Gordon B., Chen, Ken, Meric-Bernstam, Funda
I publikationen JCO Precis Oncol (2019)

Evaluating the psychometric properties of the Immunotherapy module of the MD Anderson Symptom Inventory

av Mendoza, Tito, Sheshadri, Ajay, Altan, Mehmet, Hess, Kenneth, George, Goldy, Stephen, Bettzy, Castillo, Lilibeth, Rodriguez, Enedelia, Gong, Jing, Peterson, Christine, Rodon Ahnert, Jordi, Fu, Siqing, Piha-Paul, Sarina A, Pant, Shubham, Dumbrava, Ecaterina, Yap, Timonthy A, Janku, Filip, Tsimberidou, Apostolia M, Subbiah, Vivek, Karp, Daniel D, Zarifa, Abdulrazzak, McQuinn, Lacey M, Cleeland, Charles, Hong, David S, Naing, Aung
I publikationen J Immunother Cancer (2020)

A Phase I Dose Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies

av Hegde, Aparna, Jayaprakash, Priyamvada, Couillault, Coline A., Piha-Paul, Sarina, Karp, Daniel, Rodon, Jordi, Pant, Shubham, Fu, Siqing, Ileana Dumbrava, Ecaterina E., Yap, Timothy A., Subbiah, Vivek, Bhosale, Priya, Coarfa, Cristian, Higgins, Jack P., Williams, Eric T., Wilson, Thomas F., Lim, JoAnn, Meric-Bernstam, Funda, Sumner, Elizabeth, Zain, Hira, Nguyen, Di, Nguyen, Ly, Rajapakshe, Kimal, Curran, Michael A., Hong, David S.
I publikationen Clin Cancer Res (2021)

MLTI-10. ESTABLISHMENT OF A MULTIDISCIPLINARY BRAIN METASTASIS CLINIC TO FACILITATE PATIENT-CENTERED CARE AND COORDINATED RESEARCH

av Li, Jing, Lang, Frederick F, Guha-Thakurta, Nandita, Weinberg, Jeffrey S, Rao, Ganesh, Heimberger, Amy, Ferguson, Sherise, Prabhu, Sujit, Sawaya, Raymond, Yeboa, Debra N, McAleer, Mary Frances, Chung, Caroline, Briere, Tina, Davies, Michael, de Groot, John, Glitza, Isabella, Murthy, Rashmi K, Rodon, Jordi, O’Brien, Barbara, Dumbrava, Ecaterina, Yung, W K Alfred, Vining, David, Schomer, Donald, Wang, Yan, Suki, Dima, Wozny, Mark, Zaebst, Denise, Austin, Wendy, Nguyen, Alissa, Burton, Elizabeth, Davis, Suzanne, Tawbi, Hussein
I publikationen Neurooncol Adv (2019)

Phase 2 study of pembrolizumab in patients with advanced rare cancers

av Naing, Aung, Meric-Bernstam, Funda, Stephen, Bettzy, Karp, Daniel D, Hajjar, Joud, Rodon Ahnert, Jordi, Piha-Paul, Sarina A, Colen, Rivka R, Jimenez, Camilo, Raghav, Kanwal P, Ferrarotto, Renata, Tu, Shi-Ming, Campbell, Matthew, Wang, Linghua, Sabir, Sarjeel H, Tapia, Coya, Bernatchez, Chantale, Frumovitz, Michael, Tannir, Nizar, Ravi, Vinod, Khan, Saria, Painter, Jeane M, Abonofal, Abulrahman, Gong, Jing, Alshawa, Anas, McQuinn, Lacey M, Xu, Mingxuan, Ahmed, Sara, Subbiah, Vivek, Hong, David S, Pant, Shubham, Yap, Timothy A, Tsimberidou, Apostolia M, Dumbrava, Ecaterina E Ileana, Janku, Filip, Fu, Siqing, Simon, Richard M, Hess, Kenneth R, Varadhachary, Gauri R, Amir Habra, Mouhammed
I publikationen J Immunother Cancer (2020)